Navigation Links
Lawsuit Settlement News Website Reports Update on Risperdal Litigation Due to Increase of Filed Cases
Date:8/15/2014

PHILADELPHIA, Aug. 15, 2014 /PRNewswire/ -- MT Services LLC, A Lawsuit Settlement News Reporting Company, which operates a lawsuit help center: lawsuitsettlementnews.com, announced today that there is ongoing litigation for victims of the antipsychotic drug Risperdal. The lawsuits claim that J&J failed to inform patients about potential harmful side effects. Janssen Pharmaceuticals Inc., a part of J&J and creator of Risperdal, are facing hundreds of lawsuits against them in State and Federal Courts throughout the U.S. MTS is avidly involved and dedicated in helping victims find Risperdal Lawyers, Risperdal Law Firms, or providing lawsuit cash advances if they have already retained a law firm. Clients in need of a Risperdal pre-settlement funding must have retained a lawyer first.   

To learn more about MT Services Inc. lawsuit help, product, and services, log onto: http://www.lawsuitsettlementnews.com/about-our-products-and-services

In 2012 the first settled Risperdal lawsuit was for Aaron Banks, a plaintiff who filed a suit in Pennsylvania and claimed his use of Risperdal caused Gynecomastia and psychological trauma. Several serious side effects have been documented from using Risperdal, such as Gynecomastia or male breast growth, emotional trauma, diabetes, Hyperglycemia, strokes, Tardive Dyskinesia, hyperosmolar coma, and several others. If you have experienced any of these symptoms while using Risperdal, MT Services is ready to assist you with finding a competent Risperdal attorney to provide you with a free case evaluation.   

For more information on Risperdal cases and how MTS can help visit: http://www.lawsuitsettlementnews.com/risperdal-cases

Chris Janish, CEO of MTS commented on the status of the Risperdal Litigation, "With J&J settling a $2.2 billion dollar settlement in respect to issues with how they marketed Risperdal, shows a significant concern with many aspects of the drug and its potential side effects to young adults. Lawyers in our network believe the injuries are substantial and that there is liability on J&J that will ultimately result in a global settlement down the road. As a result the cases now being filed are increasing everyday." As is with most mass tort cases, "there also remains a chance that some plaintiffs will not receive any compensation whatsoever," the company added.     

MTS is also very involved and provides updates with other bad pharmaceutical drugs such as: Actos, Avandia, Byetta, Januvia, Yaz, Yasmin, Ocella, Mirena, NuvaRing, Chantix, Pradaxa, Crestor, Depakote, Fosamax, Granuflo, Lexapro, Lipitor, Paxil, Prempro, Reglan, Steroid/Epidural Shots Causing Meningitis, Topamax, Viagra, Zoloft, and several others.

To learn more about these bad drug cases visit MTS's updated website:

http://www.lawsuitsettlementnews.com/bad-drug-case

MTS is providing lawsuit help including finding a lawyer or law firm for clients who request legal assistance, lawsuit cash advances (not to be considered lawsuit loans), surgical funding, and medical document retrieval for plaintiffs who need assistance getting medical records to assist law firms ascertain possible claims quickly. 

If you or a loved one has been injured by the Risperdal drug and need lawsuit help, including finding a Risperdal law firm or Risperdal attorney, obtaining pre-settlement lawsuit funding on your Risperdal case, or obtaining surgical funding to correct any issues in relation to Gynecomastia, call right now to speak to a live agent at 877.571.0405. You may also fill out a quick application online at: lawsuitsettlementnews.com and an agent will contact you shortly.

DISCLAIMER: MT Services LLC is not a law firm and cannot provide legal advice on your case, however MTS works with lawyers involved in mass tort litigations that will provide you with a free case evaluation at your discretion. For a list of full disclosures please visit the company's website disclosure page at: http://www.lawsuitsettlementnews.com/terms-of-service 

Contact: Chris Janish, CEO
                Ph. 877.571.0405 


'/>"/>
SOURCE MT Services LLC
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit
2. Cynosure Announces Successful Settlement of Patent Infringement Lawsuits Against Tria Beauty
3. Byetta Lawsuit News: Bernstein Liebhard LLP Notes Approval of Master Complaint in Federal Byetta Pancreatic Cancer Litigation
4. Family Talk Files Lawsuit Challenging Obamas Abortion Pill Mandate
5. Lipitor Lawsuit News: As Lipitor Diabetes Lawsuits Move Forward, Bernstein Liebhard LLP Comments on JAMA Editorial Expressing Concern about the "Statinization" of U.S.
6. As Da Vinci Robot Lawsuits Mount, Bernstein Liebhard LLP Comments on Latest Da Vinci Robot Instrument Recall
7. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Says New Study Adds to Debate Surrounding Robotic Surgery
8. Johnson & Johnson Settlement Resolves Metal Hip Lawsuits But Weak Oversight Of Medical Device Industry Leaves Hundreds of Thousands of Patients Vulnerable
9. Unilife Issues Letter to Stockholders Regarding Securities Class Action Lawsuit
10. GenVec Announces Dismissal Of Class Action Lawsuit
11. Jury Returns Verdict in RTI vs. BD Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) ... held on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, ... dedicated to helping service members that have been wounded in battle and their families. ...
(Date:6/24/2016)... ... 2016 , ... Finally, a bruise cream that really works. Originally designed ... into the post-surgical treatment plans of a variety of other procedures including, but not ... effective for bruising and causes a rapid resolution of bruising and inflammatory changes compared ...
(Date:6/24/2016)... ... 24, 2016 , ... Today, InhaleLabs.com (Inhale) offilially launched its site, ... matching users with high quality water pipes within an ideal price range. The site ... was founded by two brothers, Nick and Mike Hunter, who use medical cannabis to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Terumo BCT, ... organization responsible for clinical transfusion research programs and for the blood supply in ... Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , Currently in its ...
(Date:6/23/2016)... ... June 23, 2016 , ... The Mechille Wilson Agency, ... throughout Jasper County and the surrounding region, is initiating a charity drive to assist ... raise funds earmarked for a scholarship fund that will be presented to the chosen ...
Breaking Medicine News(10 mins):